Importance of lysosomal cysteine proteases in lung disease

Respiratory Research

Volumn 1, Issue 1, 2000, Pages

  Wolters, Paul J ^a   Chapman, Harold A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

asthma; cathepsin; emphysema; extracellular matrix; invariant chain

Indexed keywords

CATHEPSIN; CYSTEINE PROTEINASE;

ANIMAL; ANTIBODY PRODUCTION; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; IMMUNOLOGY; LUNG; LUNG DISEASE; LYSOSOME; METABOLISM; REVIEW;

ANIMAL; ANTIBODY FORMATION; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; EXTRACELLULAR MATRIX; HUMAN; LUNG; LUNG DISEASES; LYSOSOMES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0012330613     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/rr29     Document Type: Review

References (59)

1. Chapman HA Jr, Shi GP: Protease injury in the development of COPD: Thomas A. Neff Lecture. Chest 2000, 117:295S-299S.
2. Riese RJ, Chapman HA: Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol 2000, 12:107-113.
3. Hart TC, Hart PS, Bowden DW, Michalec MD, Callison SA, Walker SJ, Zhang Y, Firatli E: Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J Med Genet 1999, 36:881-887.
4. Gelb BD, Shi GP, Chapman HA, Desnick RJ: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996, 273:1236-1238.
5. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, Hewitt C, Moynihan L, Roberts E, Woods CG, Markham A, Wong M, Widmer R, Ghaffar KA, Pemberton M, Hussein IR, Temtamy SA, Davies R, Read AP, Sloan P, Dixon MJ, Thakker NS: Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999, 23:421-424.
6. Pham CTN, Armstrong RJ, Zimonjic DB, Popescu NC, Payan DG, Ley TJ: Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I. J Biol Chem 1997, 272:10695- 10703.
7. Rao NV, Rao GV, Hoidal JR: Human dipeptidyl-peptidase I. Gene characterization, localization, and expression. J Biol Chem 1997, 272:10260-10265.
8. Wolters PJ, Raymond WW, Blount JL, Caughey GH: Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I. J Biol Chem 1998, 273:15514-15520.
9. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M: Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 1996, 271:12511- 12516.
10. Bühling F, Gerber A, Häckel C, Krüger S, Köhnlein T, Brömme D, Reinhold D, Ansorge S, Welte T: Expression of cathepsin K in lung epithelial cells. Am J Resp Cell Mol Biol 1999, 20:612-619.
11. Linnevers C, Smeekens SP, Bromme D: Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Lett 1997, 405:253-259.
12. Turk B, Turk V, Turk D: Structural and functional aspects of papainlike cysteine proteinases and their protein inhibitors. Biol Chem 1997, 378:141-150.
13. Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N, Bode W: The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J 1991, 10:2321-2330.
14. Guncar G, Klemencic I, Turk B, Turk V, Karaoglanovic-Carmona A, Juliano L, Turk D: Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease. Structure Fold Des 2000, 8:305-313.
15. Guncar G, Podobnik M, Pungercar J, Strukelj B, Turk V, Turk D: Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure 1998, 6:51-61.
16. Dolenc I, Turk B, Pungercic G, Ritonja A, Turk V: Oligomeric structure and substrate induced inhibition of human cathepsin C. J Biol Chem 1995, 270:21626-21631.
17. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF: Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 1992, 282:273-278.
18. Sires UI, Schmid TM, Fliszar CJ, Wang ZQ, Gluck SL, Welgus HG: Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin- B. J Clin Invest 1995, 95:2089-2095.
19. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaissé JM: The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352.
20. Wolters PJ, Laig-Webster M, Caughey GH: Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways. Am J Respir Cell Mol Biol 2000, 22:183-190.
21. Werb Z, Bainton DF, Jones PA: Degradation of connective tissue matrices by macrophages. III. Morphological and biochemical studies on extracellular, pericellular, and intracellular events in matrix proteolysis by macrophages in culture. J Exp Med 1980, 152:1537-1553.
22. Everts V, van der Zee E, Creemers L, Beertsen W: Phagocytosis and intracellular digestion of collagen, its role in turnover and remodeling. Histochem J 1996, 28:229-245.
23. van der Zee E, Everts V, Hoeben K, Beertsen W: Cytokines modulate phagocytosis and intracellular digestion of collagen fibrils by fibroblasts in rabbit periosteal explants. Inverse effects on procollagenase production and collagen phagocytosis. J Cell Sci 1995, 108:3307-3315.
24. Everts V, Aronson DC, Beertsen W: Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 1985, 37:25-31.
25. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ: regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000, 192:789-800.
26. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999, 104: 1191-1197.
27. Heidtmann HH, Salge U, Havemann K, Kirschke H, Wiederanders B: Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines. Oncol Res 1993, 5: 441-451.
28. Pagano M, Dalet-Fumeron V, Engler R: The glycosylation state of the precursors of the cathepsin B-like proteinase from human malignant ascitic fluid: possible implication in the secretory pathway of these proenzymes. Cancer Lett 1989, 45:13-19.
29. Lorenzo K, Ton P, Clark JL, Coulibaly S, Mach L: Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6- phosphate/insulin-like growth factor II receptor. Cancer Res 2000, 60:4070-4076.
30. Dittmer F, Ulbrich EJ, Hafner A, Schmahl W, Meister T, Pohlmann R, von Figura K: Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific. J Cell Sci 1999, 112:1591-1597.
31. Stinchcombe JC, Griffiths GM: Regulated secretion from hemopoietic cells. J Cell Biol 1999, 147:1-6.
32. Brown GR, McGuire MJ, Thiele DL: Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo-activated cytotoxic T lymphocytes. J Immunol 1993, 150:4733-4742.
33. Rodriguez A, Webster P, Ortego J, Andrews NW: Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 1997, 137:93-104.
34. Jahn R, Südhof TC: Membrane fusion and exocytosis. Annu Rev Biochem 1999, 68:863-911.
35. Schiavo G, Osborne SL, Sgouros JG: Synaptotagmins: more isoforms than functions? Biochem Biophys Res Commun 1998, 248:1-8.
36. Rizo J, Südhof TC: C2-domains, structure and function of a universal Ca2+-binding domain. J Biol Chem 1998, 273:15879-15882.
37. Martinez I, Chakrabarti S, Hellevik T, Morehead J, Fowler K, Andrews NW: Synaptotagmin VII regulates Ca2+-dependent exocytosis of lysosomes in fibroblasts. J Cell Biol 2000, 148:1141-1149.
38. Petanceska S, Devi L: Sequence analysis, tissue distribution, and expression of rat cathepsin S. J Biol Chem 1992, 267:26038-26043.
39. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glossl J, Mach L: Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 1999, 83:526-531.
40. Takahashi H, Ishidoh K, Muno D, Ohwada A, Nukiwa T, Kominami E, Kira S: Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Am Rev Respir Dis 1993, 147:1562-1568.
41. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ, Chapman HA, Shapiro SD, Elias JA: Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000, 106:1081-1093.
42. McGuire MJ, Lipsky PE, Thiele DL: Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J Biol Chem 1993, 268:2458-2467.
43. Murakami M, Karnik SS, Husain A: Human prochymase activation. A novel role for heparin in zymogen processing. J Biol Chem 1995, 270:2218-2223.
44. Pham CT, Ley TJ: Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA 1999, 96:8627-8632.
45. Podack ER: How to induce involuntary suicide: the need for dipeptidyl peptidase I. Proc Natl Acad Sci USA 1999, 96:8312-8314.
46. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD: Mice lacking neutrophil elastase reveal impaired host defense against Gram-negative bacterial sepsis. Nat Med 1998, 4:615-618.
47. Belaaouaj A, Kim KS, Shapiro SD: Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science 2000, 289:1185-1188.
48. Chapman HA: Endosomal proteolysis and MHC class II function. Curr Opin Immunol 1998, 10:93-102.
49. Wolf PR, Ploegh HL: How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 1995, 11:267-306.
50. Cresswell P: Antigen presentation. Getting peptides into MHC class II molecules. Curr Biol 1994, 4:541-543.
51. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA: Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996, 4:357-366.
52. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM: Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995, 375:802-806.
53. Sherman MA, Weber DA, Jensen PE: DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995, 3:197-205.
54. Antoniou AN, Blackwood SL, Mazzeo D, Watts C: Control of antigen presentation by a single protease cleavage site. Immunity 2000, 12:391-398.
55. Watts C: Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997, 15: 821-850.
56. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA: Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999, 10:197-206.
57. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA: Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 1998, 101: 2351-2363.
58. Shi G-P BR, Riese, R, Ploegh HL, Chapman HA.: Role for cathepsin F in invariant chain processing and MHC class II peptide loading by macrophages. J Exp Med 2000, 191:1177-1185.
59. Ojcius DM, Gapin L, Kanellopoulos JM, Kourilsky P: Is antigen processing guided by major histocompatibility complex molecules? FASEB J 1994, 8:974-978.